2022 Borer Lecture with Andrea Hevener, PhD
Event Details
Location
Time
About this event
Please join us for the 2022 Katarina T. Borer Lectureship in Exercise Endocrinology & Metabolism:
"Estrogen Receptor Alpha (Esr1) Keeps Mitochondria in Shape—
Strong Enough for a Man, but Made for a Woman"
with Andrea Hevener, PhD
Professor and Roberts Chair in Molecular Endocrinology
Division of Endocrinology, Diabetes, & Hypertension
David Geffen School of Medicine
University of California, Los Angeles
Friday, October 21
Lecture: 3:30-4:30pm • SKB 2600
Reception: 4:30-5:30pm • SKB 4th Floor
830 N. University Ave., Ann Arbor, MI 48109-1048
RSVP at myumi.ch/z15Xn
Can't attend in-person? Register for the Zoom webinar instead.
We are indebted to Professor Emerita Katarina Borer and her husband Dr. Paul Wenger for their generous gift that has made this lectureship possible.
Abstract: Sex differences in metabolic disease risk and incidence are well-described. Females show a reduced incidence of metabolic-related disease compared with males. However, this female-biased protection is lost during the menopausal transition. To gain mechanistic insight into the genetic drivers underlying the impact of biological sex on metabolism, we have interrogated multi-omic analyses from numerous human observational trials, as well as a novel 100-strain mouse panel. We find that skeletal muscle expression of ESR1 (encodes ERa) is positively correlated with insulin sensitivity, negatively correlated with adiposity, and reduced in the context of metabolic syndrome in human subjects. Because differences in metabolism between the sexes are often attributed to reproductive hormones, and because skeletal muscle is a primary tissue responsible for insulin-stimulated glucose disposal, we interrogated the impact of skeletal muscle-specific Esr1 loss and gain of expression on insulin sensitivity and metabolic health in the context of nutrient and physical activity challenge. The goal of the 2022 Borer Lecture is to provide a general overview of sex as biological variable in the control metabolism and advance mechanistic insight into the critical role of ERa in the maintenance of metabolic health. In aggregate, our studies provide improved understanding of the pathobiology of metabolic disease, and lay the important foundation for enhanced therapeutic targeting of metabolism and insulin sensitivity to prevent or reverse metabolic-related disorders.